[SYRE] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Jun-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -15.95%
YoY- -41.95%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 13,696 0 0 2,378 1,479 1,373 3,427 25.94%
PBT -6,738 -21,418 -18,019 -9,414 -6,632 -5,430 -1,427 29.49%
Tax 92 0 0 0 0 0 0 -
NP -6,830 -21,418 -18,019 -9,414 -6,632 -5,430 -1,427 29.78%
Tax Rate - - - - - - - -
Total Cost 20,526 21,418 18,019 11,792 8,111 6,803 4,854 27.13%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -49.87 0.00 0.00 -395.88 -448.41 -395.48 -41.64 3.04%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -2.60 -10.11 -13.72 -11.43 -11.75 -11.53 -5.23 -10.98%
EPS Diluted -2.60 -10.11 -13.72 -11.43 -11.75 -11.53 -5.23 -10.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.